Father's Love: Novazyme Pharmaceuticals, Inc. Case Solution
This case focuses on John Crowley, CEO of Novazyme Pharmaceuticals, a start up biotechnology firm developing an orphan drug to treat a rare lysosomal storage disorder from which his kids endure, must select between a partnership and a buy out to have adequate resources and support to get the drug to the marketplace. Accompanying. this predicament are questions relating to the clinical trial strategy, advertising, sales, production, and pricing of Novazyme. This case introduces pupils to the FDA drug approval procedure and government-supported financial inducements to develop drugs for patient populations that are little. Additionally provides insight into the nature of strategic relationships in the pharmaceutical and biotechnology sectors.
This is just an excerpt. This case is about TECHNOLOGY & OPERATIONS
PUBLICATION DATE: October 22, 2002
Related Case Solutions & Analyses:
IMAX: Larger Than Life
The Ice King
How to Plan E-Business Initiatives in Established Companies
International Sourcing at Intercon
Canadian Airlines International
Glossary of TOM Terms
Following Lance Armstrong: Excellence Corrupted
Open Innovation at Siemens, Spanish Version
Applying the Service Activity Sequence in the World of Culture
Aviation Spare Parts Supply Chain Management Optimisation at Cathay Pacific Airways Limited
